ETW-31112-49878
3 vaccinations
2 coded responses
2 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 427 / KY
- Registered
- 2022-05-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Dose 1 — Pfizer-BioNTech
-
2021-04-23
Dose 2 — Pfizer-BioNTech
-
2022-03-03
Dose 3 — Pfizer-BioNTech
-
2022-05-24
Registered in v-safe
-
2022-06-02
Survey response — 3 months, dose 3MedDRA: Menstrual disorder, Oligomenorrhoea — Feeling: GoodFree text: Since getting my booster dose my menstrual cycle has changed significantly. Instead of my normal 30-32 day cycle, I am experiencing 40-43 day anovulatory cycles. (Two cycles like this so far.)MedDRA releases: 2024-11 · check-in free text available
-
2023-03-03
Survey response — 12 months, dose 3MedDRA: Essential hypertension, Pre-eclampsia, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationMedDRA releases: 2024-11
-
2023-03-03
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2023-03-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | No |
| 2 | 2021-04-23 | Pfizer-BioNTech | No |
| 3 | 2022-03-03 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 3 months, dose 3
Symptoms: Since getting my booster dose my menstrual cycle has changed significantly. Instead of my normal 30-32 day cycle, I am experiencing 40-43 day anovulatory cycles. (Two cycles like this so far.)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Essential hypertension | · | · | ✓ |
| SD | Menstrual disorder | · | · | ✓ |
| SD | Oligomenorrhoea | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release